One of Monday's biggest winners was genetic testing company Invitae (NVTA). Shares rallied more than 10% after management gave some details on current and potential future results, including guidance that was seen as favorable for 2020. While investors may be cheering the rosy forecast, this company still has a lot to prove moving forward.
First, let's look at 2019 revenues, which are forecast to be approximately $216 million. While this is a more than 45% increase over the prior year, the preliminary number missed street estimates for about $220 million. Also, original guidance